ARTV
Artiva Biotherapeutics, Inc.
6.80$
-2.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 75.9% | 73.1% | 65.5% | 66.7% | 90.0% | 88.9% | 88.0% | 87.0% | 86.0% | 83.8% | 95.6% | |
| – | 50.9% | 53.5% | 45.1% | 24.8% | 19.2% | 15.9% | 16.8% | 17.1% | 20.4% | 19.8% | 81.8% | |
| – | 73.2% | 68.9% | 61.3% | 65.0% | 88.5% | 86.8% | 84.0% | 82.6% | 82.5% | 81.9% | 94.8% | |
| – | 1.7% | 1.9% | 1.9% | 0.3% | 0.1% | 0.5% | 0.0% | 0.6% | 0.6% | 0.6% | 0.0% | |
| – | 254.1% | 293.7% | 351.7% | 10.9% | 10.9% | 11.8% | 12.0% | 13.2% | 16.0% | 17.1% | 5.7% | |
| – | 11.6% | 11.5% | 14.3% | 5.9% | 5.8% | 6.4% | 6.4% | 7.5% | 10.0% | 10.3% | 4.0% | |
| – | 3.4% | 4.0% | 5.0% | 1.7% | 1.8% | 1.9% | 2.2% | 2.1% | 2.3% | 2.9% | 0.9% | |
| – | 0.6% | 1.6% | 1.1% | 0.5% | 0.5% | 1.1% | 0.7% | 0.6% | 0.3% | 2.2% | 0.4% | |
| – | -154.1% | -193.7% | -251.7% | 89.1% | 89.1% | 88.2% | 88.0% | 86.8% | 84.0% | 82.9% | 94.3% | |
| – | -172.5% | -216.6% | -280.7% | -102.2% | -117.7% | -139.6% | -170.2% | -208.1% | -252.4% | -334.2% | -102.8% | |
| – | 19.4% | 19.5% | 30.7% | 10.8% | 11.6% | 12.7% | 14.4% | 16.4% | 18.7% | 23.3% | 10.7% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.